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Margarida Justes1, Joana Domingo1 and Manuel Portero-Otin2*Figure 1 FRAP and ABTS values in plasma of ICU polytrauma
patients (n = 73) are significantly different from those of an
age- and gender-matched population (CONTROL) (n = 102).
Asterisk indicates statistical differences according to Mann-Whitney
test (P <0.05). FRAP and ABTS in plasma were measured as described
[4] by using, respectively, 2,4,6-tri(2-piridil)-s-triazine, FeCl3, and
acetate buffer (300 mM, pH 3.6) and the ABTS radical cation (ABTS
+ ·) as reagents and by using a Beckman DU-640 spectrophotometerFindings
Oxidative stress (OS) has been invoked as a relevant fac-
tor in the evolution and outcome of critical care pa-
tients. Indeed, antioxidant therapies have been used in
critical care patients [1] but with controversial results
[2]. This may be explained by assuming OS as a home-
ostatically regulated parameter and both its excess and
its deficit influencing severity progression. Nonetheless,
antioxidant agents could mask an OS signaling role,
blocking otherwise physiological responses aimed at
recovery of homeostasis [3]. We have evaluated plasma
total antioxidant capacity (TAC) in traumatized patients
in an ICU, and we determined its potential relationship
with severity and trauma location. In a prospective
observational study of ICU polytraumatized patients
(n = 73, mean Acute Physiology and Chronic Health
Evaluation II (APACHE II) score of 11 ± 6) of the Hospital
Arnau de Vilanova (Lleida, Spain), we measured (in the
first 48 hours) plasma TAC by two different methods: the
ferric reducing activity/antioxidant power (FRAP) and the
capacity for neutralization of the free radical 2,2′-azino-
bis (3-ethylbenzothiazoline)-6-sulphonic acid (ABTS) as
previously described [4]. For control subjects, we used
age- and gender-matched volunteers (n = 102). We also
evaluated the contribution of antioxidant molecules (uric
acid, bilirubin, and albumin) to these values. The protocol
was approved by the institutional ethics committee of the
Arnau de Vilanova Hospital and followed Declaration of
Helsinki guidelines for studies with human individuals. All
participants (or their legal representatives) gave their
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2014Results
As shown in Figure 1, polytraumatized patients show
differences in TAC with reference to control subjects,
but these differences are dependent on the technique
used. Thus, ICU polytraumatized patients show higher
FRAP values but lower ABTS capacity. Notably,
APACHE II score influenced FRAP values (Table 1).
Indeed, we found that FRAP values were inversely(Beckman Instruments Inc., Fullerton, CA, USA). Both capacities were
referenced to standards containing known concentrations of
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) and
expressed as micromolar trolox equivalents (TE). ABTS, 2,2′-azino-bis
(3-ethylbenzothiazoline)-6-sulphonic acid; APACHE II, Acute Physiology
and Chronic Health Evaluation II; FRAP, ferric reducing/antioxidant
power; OS, oxidative stress; TAC, total antioxidant capacity.
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Table 1 Study population characteristics of ICU polytraumatized patients
Study population
characteristics
APACHE II score P value
≤7 (n = 28) 8-14 (n = 23) ≥15 (n = 22)
Age, yearsa 42.4 ± 14 49.9 ± 20 49.2 ± 19 0.186
Male gender 78.6 82.6 81.8 0.761
AIS (≥3)
Head 17.9 43.5 54.5 0.045
Chest 57.1 65.2 40.9 0.297
Abdomen 10.7 8.7 18.2 0.503
FRAP, μM TEb 1,093 (1,013-1,286) 1,072 (856-1,222) 825 (649-1,250) 0.044
ABTS, μM TEb 1,763 (1,555-2,035) 1,765 (1,054-2,008) 1,825 (1,405-1,982) 0.852
Uric acid, mg/dLb 3.8 (2.0-5.9) 2.5 (1.5-4.6) 2.1 (1.2-4.6) 0.056
Bilirrubin, mg/dLb 0.6 (0.4-0.9) 0.8 (0.5-1.4) 0.6 (0.5-1.2) 0.104
Albumin, mg/dLb 3.6 (3.1-3.7) 3.3 (2.7-3.6) 3.0 (2.6-3.4) 0.016
ICU mortality 0.0 0.0 13.6 0.027
Severity was staged according to Acute Physiology and Chronic Health Evaluation II (APACHE II) score. Values are presented as a percentage unless indicated
otherwise. aMean ± standard deviation; bmedian (interquartile range). P according to χ2 or Kruskal-Wallis test between different APACHE II groups. ABTS,
2,2′-azino-bis (3-ethylbenzothiazoline)-6-sulphonic acid; AIS, abbreviated injury scale; FRAP, ferric reducing/antioxidant power; ICU, intensive care unit; TE,
micromolar trolox equivalents.
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suggesting that, in trauma patients, increased antioxi-
dant response, as measured by FRAP assay, could be a
pathophysiological response to stress. Albumin and uric
acid concentrations reproduced the FRAP trend with se-
verity. Reinforcing the importance of the technique and
the specificities across different antioxidant assessment
methods, data for the relationship of APACHE II score
with ABTS do not show a significant trend (r = 0.040,
P = 0.568). These results also contrast with those obtained
in other ICU patients, such as those with sepsis [5].
In the multiple linear regression, FRAP values in
trauma ICU patients are independently influenced by
age (β = 0.271, P <0.021), APACHE II score (β = −0.356,
P <0.002), and head trauma (β = −0.219, P <0.045). These
results accentuate the influence of trauma location and
severity in TAC changes.
Our results not only stress the importance of the
method used for TAC measurement but also show that
age, status severity, and anatomical location of trauma
influence TAC response in ICU patients, reinforcing the
need for an adequate tailoring of treatments aimed at
their recovery, such as antioxidant therapies.Abbreviations
ABTS: 2,2
0
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